CTR > 0.7 predicts the subgroup of lung adenocarcinomas ≤ 2 cm at risk of poor outcome treated by sublobar resection compared to lobar resection

医学 比例危险模型 危险系数 腺癌 生存分析 回顾性队列研究 单变量分析 全肺切除术 阶段(地层学) 外科 多元分析 内科学 胃肠病学 癌症 置信区间 古生物学 生物
作者
Weiwei Jing,Qi Li,Mengxi Liu,Yi Zhang,Sifan Chen,Ke Zhang,Dan Li,Min Zhao,Yineng Zheng,Wang-jia Li,Yangying Wu,Hongbo Xu,Ziya Zhao,Shaolei Kang,Fajin Lv
出处
期刊:Cancer Imaging [BioMed Central]
卷期号:24 (1)
标识
DOI:10.1186/s40644-024-00717-4
摘要

Abstract Background A standard surgical procedure for patients with small early-stage lung adenocarcinomas remains unknown. Hence, we aim in this study to assess the clinical utility of the consolidation-to-tumor ratio (CTR) when treating patients with small (2 cm) early stage lung cancers. Methods A retrospective cohort of 298 sublobar resection and 266 lobar resection recipients for early stage lung adenocarcinoma ≤ 2 cm was assembled from the First Affiliated Hospital of Chongqing Medical University between 2016 and 2019. To compare survival rates among the different groups, Kaplan-Meier curves were calculated, and the log-rank test was used. A multivariate Cox proportional hazard model was constructed utilizing variables that were significant in univariate analysis of survival. Results In the study, 564 patients were included, with 298 patients (52.8%) undergoing sublobar resection and 266 patients (47.2%) undergoing lobar resection. Regarding survival results, there was no significant difference in the 5-year overall survival (OS, P = 0.674) and 5-year recurrence-free survival (RFS, P = 0.253) between the two groups. Cox regression analyses showed that CTR ≥ 0.75( P < 0.001), age > 56 years ( P = 0.007), and sublobar resection( P = 0.001) could predict worse survival. After examining survival results based on CTR categorization, we segmented the individuals into three categories: CTR<0.7, 0.7 ≤ CTR<1, and CTR = 1.The lobar resection groups had more favorable clinical outcomes than the sublobar resection groups in both the 0.7 ≤ CTR < 1(RFS: P < 0.001, OS: P = 0.001) and CTR = 1(RFS: P = 0.001, OS: P = 0.125). However, for patients with 0 ≤ CTR < 0.7, no difference in either RFS or OS was found between the lobar resection and sublobar resection groups, all of which had no positive events. Patients with a CTR between 0.7 and 1 who underwent lobar resection had similar 5-year RFS and OS rates compared to those with a CTR between 0 and 0.7 who underwent sublobar resection (100% vs. 100%). Nevertheless, a CTR of 1 following lobar resection resulted in notably reduced RFS and OS when compared to a CTR between 0.7 and 1 following lobar resection ( P = 0.005 and P = 0.016, respectively). Conclusion Lobar resection is associated with better long-term survival outcomes than sublobar resection for small lung adenocarcinomas ≤ 2 cm and CTR ≥ 0.7.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
一地狗粮完成签到,获得积分10
1秒前
chali48完成签到 ,获得积分10
1秒前
1秒前
2秒前
malen111发布了新的文献求助10
2秒前
过往匆匆发布了新的文献求助10
3秒前
付品聪发布了新的文献求助10
6秒前
7秒前
陶醉妙松完成签到,获得积分10
7秒前
丰富语蕊应助古韵采纳,获得10
7秒前
7秒前
TingtingGZ发布了新的文献求助10
9秒前
9秒前
9秒前
lnyklz完成签到 ,获得积分10
10秒前
11秒前
dde发布了新的文献求助10
12秒前
13秒前
sun发布了新的文献求助10
13秒前
14秒前
ding应助花花采纳,获得10
14秒前
16秒前
林红刚完成签到,获得积分10
16秒前
小羊完成签到,获得积分20
16秒前
17秒前
酷波er应助czl采纳,获得10
17秒前
18秒前
LHP发布了新的文献求助10
19秒前
20秒前
TingtingGZ完成签到,获得积分10
21秒前
22秒前
23秒前
dde发布了新的文献求助10
24秒前
24秒前
25秒前
lll完成签到 ,获得积分10
26秒前
刘赟完成签到,获得积分10
28秒前
Cher应助gqp采纳,获得10
29秒前
玛卡巴卡发布了新的文献求助10
31秒前
我是老大应助杨和采纳,获得10
32秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Markov Chain Monte Carlo 5000
Weaponeering: An Introduction Fourth Edition, Volume 1 1000
Advanced Weaponeering Fourth Edition, Volume 2 1000
Evidence Summary. Injection (subcutaneous):op- timal administration 1000
悉尼大学博士学位论文,题目:Modelling and testing of one-sided stitched laminated composites. 作者:Kristopher P. Plain 700
Matrix Methods in Data Mining and Pattern Recognition Second Edition 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7494167
求助须知:如何正确求助?哪些是违规求助? 9085664
关于积分的说明 19377300
捐赠科研通 7106063
什么是DOI,文献DOI怎么找? 3249687
关于科研通互助平台的介绍 2419124
邀请新用户注册赠送积分活动 2235379